Adam Dorfman

Adam Dorfman is the current Executive Director of Quality Control & Bioanalytical at Clene Nanomedicine. Adam has been with the company for 9 years and 5 months, and has held various titles during their tenure, including VP, Quality & Technical Operations, Executive Director, Quality Control & Bioanalytical, Director of Quality Control and Bioanalytical Lab, and Director of Bioanalytics. In their current role, Adam oversees the Bioanalytical and Quality Control Lab in support of both the GMP drug production facility and external GLP and GCP studies. Adam also assists in the management of external pre-clinical studies, and reports directly to the Chief Medical Officer to provide support for regulatory filings. Adam works closely with Quality Assurance to ensure that all applicable regulations are met, and leads method development and validation.

Prior to joining Clene Nanomedicine, Adam was a Consultant with Autism Speaks for 12 years and 3 months. In this role, they oversaw the planning and execution of the Pennsylvania State University Autism Speaks U 5k Race/3k Walk, provided program level guidance to the Autism Speaks U program (Co-creator), and ensured that event goals were met by evaluating metrics on a regular basis.

Before their time with Autism Speaks, Adam was a Senior Research Engineer with General Resonance, LLC for 5 years and 9 months. In this role, they provided patent support through the generation of figures and written experimental examples. Adam also researched Gold/Platinum nanoparticles and their effects on cancer in in vivo models, conducted in vitro testing of proprietary metallic compounds against E.coli and other bacteria, and experimented with novel catalysts in PEMFC.

Adam Dorfman attended The Johns Hopkins University from 2008 until 2011, where they earned their Masters in Chemical and Biomolecular Engineering. Adam attended Penn State University from 2003 until 2007, where they earned their degree in Chemical Engineering.

The colleagues of Adam Dorfman work with him in different capacities in order to help him with their job as the Executive Director of Quality Control and Bioanalytical. Adam's colleagues include the Chief Financial Officer, the Chief Development Officer, the Head of Human Resources, the Executive Director of Nano Engineering, the Chief Medical Officer, the General Counsel and Corporate Secretary, the Executive Director of Production and Manufacturing, the Senior Director of Quality Assurance, and the Head of Translational Medicine.